Clinical Trial Update: The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of intravenous anidulafungin for azole-refractory mucosal candidiasis (FRMC). The study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Mucosal Candidiasis

Drugs mentioned

• Anidulafungin (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidiasis | Phase 2 | Status: COMPLETED